𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease in Adults

✍ Scribed by Malinowski, Scott S.; Byrd, Jennifer S.; Bell, Allison M.; Wofford, Marion R.; Riche, Daniel M.

Book ID
120039811
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
114 KB
Volume
33
Category
Article
ISSN
0277-0008

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Valproate therapy and nonalcoholic fatty
Valproate therapy and nonalcoholic fatty liver disease
✍ Gerhard J. Luef; Markus Waldmann; Wolfgang Sturm; Anis Naser; Eugen Trinka; Iris πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 1 views

## Abstract Nonalcoholic fatty liver disease was defined recently as another symptom of insulin resistance. Continuous therapy with valproate can result in increased body weight and insulin resistance, but no data are yet available on a possible relationship between valproate and nonalcoholic fatty

Nonalcoholic fatty liver disease after l
Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
✍ Kanthi Yalamanchili; Sherif Saadeh; GΓΆran B. Klintmalm; Linda W. Jennings; Gary πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples